DK665187A - Immunoglobulin-konjugater og fremgangsmaade til fremstilling heraf - Google Patents

Immunoglobulin-konjugater og fremgangsmaade til fremstilling heraf

Info

Publication number
DK665187A
DK665187A DK665187A DK665187A DK665187A DK 665187 A DK665187 A DK 665187A DK 665187 A DK665187 A DK 665187A DK 665187 A DK665187 A DK 665187A DK 665187 A DK665187 A DK 665187A
Authority
DK
Denmark
Prior art keywords
procedures
preparing
immunoglobulin conjugates
conjugates
immunoglobulin
Prior art date
Application number
DK665187A
Other languages
English (en)
Other versions
DK665187D0 (da
Inventor
Gary Allen Koppel
George Davon Kennedy
Henry Kenneth Armour
William Leonard Scott
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK665187D0 publication Critical patent/DK665187D0/da
Publication of DK665187A publication Critical patent/DK665187A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DK665187A 1986-12-24 1987-12-17 Immunoglobulin-konjugater og fremgangsmaade til fremstilling heraf DK665187A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94635186A 1986-12-24 1986-12-24

Publications (2)

Publication Number Publication Date
DK665187D0 DK665187D0 (da) 1987-12-17
DK665187A true DK665187A (da) 1988-06-25

Family

ID=25484355

Family Applications (1)

Application Number Title Priority Date Filing Date
DK665187A DK665187A (da) 1986-12-24 1987-12-17 Immunoglobulin-konjugater og fremgangsmaade til fremstilling heraf

Country Status (14)

Country Link
EP (1) EP0272891A3 (da)
JP (1) JPS63166897A (da)
KR (1) KR880007531A (da)
CN (1) CN1018649B (da)
AU (1) AU590462B2 (da)
DK (1) DK665187A (da)
HU (1) HU205135B (da)
IE (1) IE873450L (da)
IL (1) IL84842A0 (da)
MX (1) MX9847A (da)
NZ (1) NZ222981A (da)
PT (1) PT86377B (da)
RU (1) RU1787160C (da)
ZA (1) ZA879473B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1312599C (en) * 1988-02-16 1993-01-12 Larry Wayne Hertel 2',3'dideoxy-2',2'difluoronucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5273743A (en) * 1990-03-09 1993-12-28 Hybritech Incorporated Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
IL97459A0 (en) * 1990-03-09 1992-06-21 Hybritech Inc Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
WO1992014758A1 (en) * 1991-02-13 1992-09-03 The Austin Research Institute Conjugate molecules
CN1076197C (zh) * 1997-08-20 2001-12-19 许跃远 一种治疗乳腺疾病的药
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
US7435755B2 (en) 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
DK1465615T3 (da) 2002-01-15 2012-11-12 Dartmouth College Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf
WO2004041203A2 (en) 2002-11-04 2004-05-21 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
US8921340B2 (en) 2006-11-17 2014-12-30 Trustees Of Dartmouth College Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
EP2094651A1 (en) 2006-11-17 2009-09-02 Trustees Of Dartmouth College Synthesis and biological activities of new tricyclic-bis-enones (tbes)
WO2008064132A2 (en) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
ME03529B (me) 2008-01-11 2020-04-20 Reata Pharmaceuticals Inc Sintetički triterpenoidi i metode njihove upotrebe u tretmanu bolesti
EP2279197B1 (en) 2008-04-18 2014-11-05 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
HUE033288T2 (en) 2008-04-18 2017-11-28 Reata Pharmaceuticals Inc Antioxidant inflammation modulators: C-17 homologated oleic acid derivatives
RS58392B1 (sr) 2008-04-18 2019-04-30 Reata Pharmaceuticals Inc Antioksidantni modulatori inflamacije: derivati oleanoličke kiseline sa amino i drugim modifikacijama na c-17
TW201006474A (en) 2008-04-18 2010-02-16 Reata Pharmaceuticals Inc Natural products including an anti-flammatory pharmacore and methods of use
US8071632B2 (en) 2008-04-18 2011-12-06 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
US8752322B2 (en) 2012-01-13 2014-06-17 Taurus International Manufacturing, Inc. Body contoured handgun
EP2833905B1 (en) 2012-04-04 2018-05-02 Halozyme, Inc. Combination therapy with hyaluronidase and a tumor-targeted taxane
US8921419B2 (en) 2012-05-08 2014-12-30 Trustees Of Dartmouth College Triterpenoids and compositions containing the same
WO2019222435A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
CN108610384B (zh) * 2018-05-31 2022-02-22 沈阳药科大学 基于肠道mct1载体蛋白设计的前药及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
GR79899B (da) * 1983-03-30 1984-10-31 Lilly Industries Ltd
DE3483336D1 (de) * 1983-03-30 1990-11-08 Lilly Industries Ltd Vincaleukoblastin-derivate.
US4650675A (en) * 1983-08-18 1987-03-17 The Children's Medical Center Corporation Oligonucleotide conjugates
DE3587500T2 (de) * 1984-12-04 1993-12-16 Lilly Co Eli Tumorbehandlung bei Säugetieren.
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents
US4762823A (en) * 1985-10-16 1988-08-09 Sloan-Kettering Institute For Cancer Research Nucleosides of 5-monofluoromethyluracil and 5-difluoromethyluracil
US4751221A (en) * 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides

Also Published As

Publication number Publication date
KR880007531A (ko) 1988-08-27
DK665187D0 (da) 1987-12-17
EP0272891A3 (en) 1989-11-08
JPS63166897A (ja) 1988-07-11
HUT45547A (en) 1988-07-28
RU1787160C (ru) 1993-01-07
EP0272891A2 (en) 1988-06-29
CN1018649B (zh) 1992-10-14
IE873450L (en) 1988-06-24
AU8265987A (en) 1988-06-30
HU205135B (en) 1992-03-30
IL84842A0 (en) 1988-06-30
ZA879473B (en) 1989-08-30
PT86377A (en) 1988-01-01
CN87108348A (zh) 1988-07-13
NZ222981A (en) 1989-08-29
AU590462B2 (en) 1989-11-02
MX9847A (es) 1993-11-01
PT86377B (pt) 1990-11-20

Similar Documents

Publication Publication Date Title
DK665187D0 (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling heraf
DK260687A (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf
DK664887D0 (da) 3-substituerede 3-aroyloxy-propanaminer og fremgangsmaade til fremstilling deraf
DK166087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK484587A (da) Antioxidant og fremgangsmaade til fremstilling heraf
DK522487D0 (da) Imidazopyridinforbindelse og fremgangsmaade til fremstilling deraf
DK301886A (da) Furanon-derivater og fremgangsmaade til fremstilling heraf
DK130182A (da) Antagonister for argininvasopressin og fremgangsmaade til fremstilling heraf
DK134288D0 (da) Kemo-radio-immuno-konjugat og fremgangsmaade til fremstilling heraf
DK315085A (da) Isoinsolinyl-alkyl-piperaziner og fremgangsmaade til fremstilling deraf
DK564889D0 (da) Fastgoerelseselement og fremgangsmaade til fremstilling heraf
DK477287A (da) Pyrido-benzoxadiazin-derivater og fremgangsmaade til fremstilling deraf
DK203087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK32989D0 (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf
DK103889D0 (da) Benzimidazooe1,2-caachinazoliner og fremgangsmaade til fremstilling heraf
NO873197D0 (no) Bedoevelsespreparat og fremgangsmaate for anvendelse av dette.
DK362987D0 (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
DK487688D0 (da) Benzofuranderivater og fremgangsmaade til fremstilling deraf
DK454684A (da) 7beta-acylamino-3-azido-cephalosporiner og fremgangsmaade til fremstilling heraf
DK454784D0 (da) 6-oxodecahydroquinoliner og fremgangsmaade til fremstilling heraf
DK25388A (da) Kondenserede pyrazolderivater og fremgangsmaade til fremstilling heraf
DK624588D0 (da) 4-demethoxy-anthracyclin-derivater og fremgangsmaade til fremstilling deraf
DK129689A (da) Ifosfamid-mesna-lyofilisat og fremgangsmaade til fremstilling deraf
DK160087D0 (da) Katalysatorkomponent og fremgangsmaade til fremstilling deraf
DK112682A (da) Azaspiroalkandioner og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment